top of page
1. PlasmarkAD® risk level
(High-moderate-low)
The earliest possible AD detection can begin at the asymptomatic stage.
High risk
2. PlasmarkAD® prognosis
with 5 AD-associated pathways
Neurodegeneration
Vascular Function
Metabolic Pathway
Innate Immunity
Inflammation
bottom of page